Company Filing History:
Years Active: 2001-2008
Title: The Innovative Contributions of Frederick Ray Kinder, Jr.
Introduction
Frederick Ray Kinder, Jr. is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. With a total of 11 patents to his name, Kinder's work exemplifies the intersection of innovation and healthcare.
Latest Patents
Among his latest patents, Kinder has developed "Substituted lactams and their use as anti-cancer agents." This invention focuses on certain substituted lactam compounds, particularly caprolactam compounds, which are useful for the treatment of cancer. Another significant patent is for "Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors." This invention relates to specific substituted polyketides and their pharmaceutical applications in treating tumors.
Career Highlights
Frederick Ray Kinder, Jr. has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis AC. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of medicinal chemistry.
Collaborations
Throughout his career, Kinder has collaborated with esteemed colleagues such as Kenneth Walter Bair and Richard William Versace. These partnerships have fostered an environment of innovation and have led to the advancement of various pharmaceutical technologies.
Conclusion
Frederick Ray Kinder, Jr. stands out as a significant figure in the realm of pharmaceutical inventions. His contributions, particularly in cancer treatment, highlight the importance of innovation in improving healthcare outcomes.